Nephrotic Syndrome 2

15 Apr 2024 5:45 p.m. 6:45 p.m.

MON-305 to MON-312

Fernando Fervenza Poster Moderator

Time	Session

5:45 p.m. 6:45 p.m.	NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION WCN24-AB-1921, Poster Board= MON-305 MON-305	The use of rituximab in childhood steroid-resistant nephrotic syndrome: an international, multi-centre study WCN24-AB-1789, Poster Board= MON-306 MON-306 Eugene Yu Hin Chan Poster Presenter	THE EFFICIENCY AND SAFETY OF OBINUTUZUMAB IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY-A RETROSPECTIVE STUDY FROM CHINA WCN24-AB-1086, Poster Board= MON-307 MON-307 Chen Duqun Poster Presenter	PREDICTING PATIENT RESPONSE TO STANDARD-OF-CARE THERAPIES IN GLOMERULAR DISEASES WCN24-AB-385, Poster Board= MON-308 MON-308 Sean Eddy Poster Presenter	EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NEPHROTIC SYNDROME: A MULTI-INSTITUTIONAL ANALYSIS WCN24-AB-409, Poster Board= MON-309 MON-309 Brittany Miles Poster Presenter	ROLE OF RITUXIMAB IN LONG TERM REMISSION OF IDIOPATHIC STEROID DEPENDENT & FREQUENTLY RELAPSING CHILDHOOD ONSET NEPHROTIC SYNDROME WCN24-AB-2162, Poster Board= MON-310 MON-310 Arjun Ray Poster Presenter	PROLONGED REMISSION AFTER CYCLOPHOSPHAMIDE AND TACROLIMUS TREATMENT IN CHILDHOOD NEPHROTIC SYNDROME: A PROSPECTIVE COHORT STUDY WCN24-AB-636, Poster Board= MON-311 MON-311 Cal Robinson Poster Presenter	BIOMOLECULAR ANALYSIS OF URINE FROM PATIENTS WITH NEPHROTIC SYNDROME USING FOURIER-TRANSFORM INFRARED SPECTROSCOPY (FTIR) WCN24-AB-2226, Poster Board= MON-312 MON-312 Edson Olaf Romero Cázares Poster Presenter